跳转至内容
Merck
CN

C9487

Sigma-Aldrich

抗-降钙素基因相关肽单克隆抗体 小鼠抗

clone CD8, purified immunoglobulin, buffered aqueous solution

别名:

抗 CGRP

登录查看公司和协议定价


About This Item

MDL编号:
UNSPSC代码:
12352203
NACRES:
NA.41

生物来源

mouse

质量水平

偶联物

unconjugated

抗体形式

purified immunoglobulin

抗体产品类型

primary antibodies

克隆

CD8, monoclonal

表单

buffered aqueous solution

种属反应性

guinea pig, human

技术

immunocytochemistry: suitable
immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:200-1:1,000 using ovenight incubation at 4 °C and sections that have been protease-digested or processed by high temperature antigen retrieval
indirect immunofluorescence: 1:500 using overnight incubation at 4 °C

同位素/亚型

IgG1

UniProt登记号

运输

dry ice

储存温度

−20°C

靶向翻译后修饰

unmodified

基因信息

human ... CALCA(796)
rat ... Calca(24241)

正在寻找类似产品? 访问 产品对比指南

一般描述

降钙素基因相关肽(CGRP)是一种血管舒张剂,属于降钙素肽家族。它由周围和中枢神经紧张系统的运动神经元产生。CGRP有两种形式,α和β,它们具有相似的功能。CGRP的作用是由降钙素受体样受体(CRLR)和受体活性修饰蛋白1(RAMP1)形成的G蛋白偶联受体异二聚体介导的。 CGRP在神经紧张、内分泌、免疫和心血管系统中具有多种生物学作用。 多项研究表明CGRP与偏头痛的病理生理有关,并且正在探索CGRP的拮抗剂作为治疗的选择。
单克隆抗降钙素基因相关肽(CGRP)可识别人和豚鼠CGRP。与大鼠CGRP无交叉反应。

免疫原

对应于大鼠α−降钙素基因相关肽(CGRP)C末端的肽。

应用

抗降钙素基因相关肽(CGRP)抗体适用于使用福尔马林固定、石蜡包埋切片或低温恒温器组织切片以1:200至1:1000的工作抗体稀释度进行免疫组化。该抗体可用于免疫荧光,其工作稀释度为1:500。

外形

含1%BSA和≤0.1%叠氮化钠的PBS溶液

免责声明

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

未找到合适的产品?  

试试我们的产品选型工具.

储存分类代码

10 - Combustible liquids

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

法规信息

常规特殊物品
含少量动物源组分生物产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

C Juaneda et al.
Trends in pharmacological sciences, 21(11), 432-438 (2000-12-21)
Calcitonin gene-related peptides (alpha and beta isoforms), better known as CGRPalpha and CGRPbeta, were isolated twenty years ago. In fact, these were the first peptides to be characterized using a molecular cloning strategy, which is not the traditional approach of
Udayasankar Arulmani et al.
European journal of pharmacology, 500(1-3), 315-330 (2004-10-07)
Migraine is a common neurological disorder that is associated with an increase in plasma calcitonin gene-related peptide (CGRP) levels. CGRP, a neuropeptide released from activated trigeminal sensory nerves, dilates intracranial blood vessels and transmits vascular nociception. Therefore, it is propounded
T Esfandyari et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 14(10), 1439-1446 (2000-07-06)
The receptor responsible for CGRP-induced ion transport and permeability was examined in tissues from animals treated 7 days previously with trinitrobenzenesulfonic acid to induce colitis or in controls. CGRP caused a concentration-dependent increase in short circuit current (I(sc), EC(50) 21
P-C Fan et al.
Cephalalgia : an international journal of headache, 29(8), 883-890 (2009-02-25)
To investigate the role of plasma calcitonin gene-related peptide (CGRP) in paediatric migraine, we prospectively collected 134 blood samples during or between attacks from 66 migraine, 33 non-migraine headache (non-migraine) and 22 non-headache patients, aged 4-18 years. Plasma CGRP concentrations
Jochen K Lennerz et al.
The Journal of comparative neurology, 507(3), 1277-1299 (2008-01-11)
Calcitonin gene-related peptide (CGRP) is a key mediator in primary headaches including migraine. Animal models of meningeal nociception demonstrate both peripheral and central CGRP effects; however, the target structures remain unclear. To study the distribution of CGRP receptors in the

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门